Literature DB >> 30814820

Exercise Improves Recognition Memory and Acetylcholinesterase Activity in the Beta Amyloid-Induced Rat Model of Alzheimer's Disease.

Mohammad Amin Farzi1,2, Saeed Sadigh-Eteghad1, Khadijeh Ebrahimi3, Mahnaz Talebi1,2.   

Abstract

OBJECTIVE: A correlation between physical exercise and cognitive improvement has been found in Alzheimer's disease (AD). This study aimed to investigate the effects of aerobic and resistance exercise on the recognition memory and acetylcholinesterase (AChE) activity in beta amyloid (Aβ) model of AD in rat.
MATERIALS AND METHODS: Fifty male 8-week-old Wistar rats (250-280 g) were divided into 5 groups (n = 10 each) of control, sham surgery, Aβ-received sedentary, Aβ-received with aerobic exercise and Aβ-received with resistance exercise. AD was induced by intracerebroventricular injection of Aβ25-35 peptide. The sham surgery group received normal saline using the same route and condition. Two groups of Aβ-received animals were trained by treadmill for aerobic exercise and by ladder for strength exercise for 8 weeks (4 days/week). Novel object recognition (NOR) task was used to assess recognitional memory in groups. AChE activity in the brain tissue was assessed using the Spectrophotometry method.
RESULTS: There was no significant difference in memory index and AChE activity between the sham surgery and control groups (p > 0.05). Also, impairment of NOR indices was seen in the Aβ-injected sedentary rats (p < 0.05). However, both aerobic and strength training improved the exploration index in this test (p < 0.05). Further, AChE activity increased in the Aβ-injected sedentary group but declined in the aerobic and resistance exercise groups (p < 0.01).
CONCLUSION: Aerobic and resistance exercise could improve recognition memory and decrease AChE activity in Aβ-induced AD in rats. The decrease in AChE activity may be one of the mechanisms by which exercise improves cognition and memory in AD.

Entities:  

Keywords:  Acetylcholinesterase; Aerobic exercise; Alzheimer's disease; Beta amyloid; Resistance exercise

Year:  2018        PMID: 30814820      PMCID: PMC6388429          DOI: 10.1159/000488580

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  42 in total

Review 1.  Neuropathology of Alzheimer's disease and other dementias.

Authors:  D W Dickson
Journal:  Clin Geriatr Med       Date:  2001-05       Impact factor: 3.076

Review 2.  Cholinergic hypothesis of Alzheimer's disease: biophysical aspects.

Authors:  P R Adams
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1987

Review 3.  Molecular Pathogenesis of Alzheimer's Disease: An Update.

Authors:  Alfredo Sanabria-Castro; Ileana Alvarado-Echeverría; Cecilia Monge-Bonilla
Journal:  Ann Neurosci       Date:  2017-04-21

4.  Treadmill Running Reverses Cognitive Declines due to Alzheimer Disease.

Authors:  Jinkyung Cho; Min-Kyoo Shin; Donghyun Kim; Inhwan Lee; Shinuk Kim; Hyunsik Kang
Journal:  Med Sci Sports Exerc       Date:  2015-09       Impact factor: 5.411

Review 5.  Neuropathology in Alzheimer's disease: target of pharmacotherapy.

Authors:  Elaine Souder
Journal:  J Am Acad Nurse Pract       Date:  2005-03

6.  Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model.

Authors:  Hyun Seob Um; Eun Bum Kang; Yea Hyun Leem; In Ho Cho; Chun Ho Yang; Kab Ryong Chae; Dae Youn Hwang; Joon Yong Cho
Journal:  Int J Mol Med       Date:  2008-10       Impact factor: 4.101

Review 7.  Astrocytic and microglial nicotinic acetylcholine receptors: an overlooked issue in Alzheimer's disease.

Authors:  Saeed Sadigh-Eteghad; Alireza Majdi; Javad Mahmoudi; Samad E J Golzari; Mahnaz Talebi
Journal:  J Neural Transm (Vienna)       Date:  2016-06-04       Impact factor: 3.575

8.  Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study.

Authors:  Pei-Ning Wang; Chueh-Lien Yang; Ker-Neng Lin; Wei-Ta Chen; Leh-Chii Chwang; Hsiu-Chih Liu
Journal:  J Neurol       Date:  2004-03       Impact factor: 4.849

9.  Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Carla M Yuede; Scott D Zimmerman; Hongxin Dong; Matthew J Kling; Adam W Bero; David M Holtzman; Benjamin F Timson; John G Csernansky
Journal:  Neurobiol Dis       Date:  2009-06-12       Impact factor: 5.996

Review 10.  Amyloid-beta: a crucial factor in Alzheimer's disease.

Authors:  Saeed Sadigh-Eteghad; Babak Sabermarouf; Alireza Majdi; Mahnaz Talebi; Mehdi Farhoudi; Javad Mahmoudi
Journal:  Med Princ Pract       Date:  2014-11-27       Impact factor: 1.927

View more
  10 in total

1.  Exercise enhances the effectiveness of vitamin D therapy in rats with Alzheimer's disease: emphasis on oxidative stress and inflammation.

Authors:  Engy Medhat; Laila Rashed; Marwa Abdelgwad; Basma Emad Aboulhoda; Mohamed Mansour Khalifa; Shimaa Saad El-Din
Journal:  Metab Brain Dis       Date:  2019-11-05       Impact factor: 3.584

2.  Neuroprotective Effect of 2-Aminoethoxydiphenyl Borate (2-APB) in Amyloid β-Induced Memory Dysfunction: A Mechanistic Study.

Authors:  Pavan Thapak; Pragyanshu Khare; Mahendra Bishnoi; Shyam Sunder Sharma
Journal:  Cell Mol Neurobiol       Date:  2020-11-21       Impact factor: 5.046

3.  Evidence for preserved insulin responsiveness in the aging rat brain.

Authors:  Matthew G Engel; Jeremy Smith; Kai Mao; Gabriela Farias Quipildor; Min-Hui Cui; Maria Gulinello; Craig A Branch; Samuel E Gandy; Derek M Huffman
Journal:  Geroscience       Date:  2022-07-08       Impact factor: 7.581

Review 4.  Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.

Authors:  Boyi Zong; Fengzhi Yu; Xiaoyou Zhang; Wenrui Zhao; Peng Sun; Shichang Li; Lin Li
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

Review 5.  Effects of Resistance Exercise on Cerebral Redox Regulation and Cognition: An Interplay Between Muscle and Brain.

Authors:  Ricardo A Pinho; Aderbal S Aguiar; Zsolt Radák
Journal:  Antioxidants (Basel)       Date:  2019-11-06

6.  Andrographolide emeliorates maltol aluminium-induced neurotoxicity via regulating p62-mediated Keap1-Nrf2 pathways in PC12 cells.

Authors:  Jiaqi Lu; Lili Gu; Qin Li; Ningzi Wu; Hongxing Li; Xinyue Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 7.  Dissecting Sex-Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies.

Authors:  Ghulam Md Ashraf; Mahmoud Ahmed Ebada; Mohd Suhail; Ashraf Ali; Md Sahab Uddin; Anwar L Bilgrami; Asma Perveen; Amjad Husain; Mohd Tarique; Abdul Hafeez; Athanasios Alexiou; Ausaf Ahmad; Rajnish Kumar; Naheed Banu; Agnieszka Najda; Amany A Sayed; Ghadeer M Albadrani; Mohamed M Abdel-Daim; Ilaria Peluso; George E Barreto
Journal:  Oxid Med Cell Longev       Date:  2021-03-05       Impact factor: 6.543

8.  Acetylcholine deficiency disrupts extratelencephalic projection neurons in the prefrontal cortex in a mouse model of Alzheimer's disease.

Authors:  Qingtao Sun; Jianping Zhang; Anan Li; Mei Yao; Guangcai Liu; Siqi Chen; Yue Luo; Zhi Wang; Hui Gong; Xiangning Li; Qingming Luo
Journal:  Nat Commun       Date:  2022-02-22       Impact factor: 14.919

9.  Neuroprotective effects of strength training in a neuroinflammatory animal model.

Authors:  Elizama de Gregório; Gabriela Cristiane Mendes; Lincon Bordignon Somensi; Cassio Geremia Freire; Luiza Freitas Lopes; Karine Ramires Lima; Guilherme Salgado Carrazoni; Ben-Hur Souto Neves; Steffanie Severo Picua; Luisa Mota da Silva; Pamela Billig Mello-Carpes; Juliana Sartori Bonini; Weber Claudio da Silva
Journal:  BMC Neurosci       Date:  2022-04-11       Impact factor: 3.288

10.  Tranilast, a Transient Receptor Potential Vanilloid 2 Channel (TRPV2) Inhibitor Attenuates Amyloid β-Induced Cognitive Impairment: Possible Mechanisms.

Authors:  Pavan Thapak; Mahendra Bishnoi; Shyam Sunder Sharma
Journal:  Neuromolecular Med       Date:  2021-07-06       Impact factor: 3.843

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.